Use of evidence-based medicine for acute coronary syndromes in the elderly and very elderly: Insights from the Sibrafiban vs aspirin to Yield Maximum Protection from ischemic heart events postacute cOroNary sYndromes trials
Wong, Cheuk-Kit × Newby, L. Kristin Bhapker, Manju V Aylward, Phil E Pfisterer, Matthias Alexander, Karen P Armstrong, Paul W Hochman, Judith S Van de Werf, Frans Califf, Robert M White, Harvey D #
American heart journal vol:154 issue:2 pages:313-321
Background Evidence-based-medications (EBM) are underused in older patients despite potentially larger absolute benefits. Little is known about factors influencing prescribing in the elderly with acute coronary syndromes.